AyuVis

About:

AyuVis is a start-up biopharmaceutical company, developing a new class of immunotherapies to prevent and treat inflammation and infection.

Website: https://www.ayuvis.com

Top Investors: National Heart, Lung and Blood Institute, The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Description:

AyuVis is a start-up biopharmaceutical company, developing a new class of immunotherapies to prevent and treat inflammation and infection. Its focus is on the development of the New Molecular Entities (NME)/ New Technologies as immune-modulating, anti-infective, and anti-inflammatory drugs. It is developing proprietary small molecule therapeutics, which have the potential to transform the treatment prospects for patients with life-threatening respiratory conditions including bronchopulmonary dysplasia, Pseudomonas aeruginosa pneumonia, cystic fibrosis, ARDS, COPD, and other inflammatory or infectious diseases. Suchismita Acharya founded the biotech company in 2014 and is based in Fort Worth, Texas.